GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by Abner Herrman & Brock LLC

Abner Herrman & Brock LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 127,878 shares of the company’s stock after purchasing an additional 1,026 shares during the period. Abner Herrman & Brock LLC’s holdings in GE HealthCare Technologies were worth $9,997,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. State Street Corp increased its stake in GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company’s stock valued at $1,747,101,000 after buying an additional 1,347,114 shares during the period. Geode Capital Management LLC boosted its position in shares of GE HealthCare Technologies by 7.2% during the 3rd quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company’s stock valued at $1,026,898,000 after purchasing an additional 733,819 shares in the last quarter. D1 Capital Partners L.P. bought a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth approximately $268,159,000. Charles Schwab Investment Management Inc. grew its position in GE HealthCare Technologies by 12.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,710,938 shares of the company’s stock worth $254,422,000 after buying an additional 290,019 shares during the last quarter. Finally, Van ECK Associates Corp bought a new position in shares of GE HealthCare Technologies in the third quarter valued at $208,513,000. Institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

GEHC has been the topic of a number of recent research reports. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have given a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

GE HealthCare Technologies Stock Down 1.4 %

GEHC stock opened at $88.30 on Monday. The stock has a market capitalization of $40.34 billion, a price-to-earnings ratio of 24.26, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. The company has a 50-day moving average of $82.87 and a two-hundred day moving average of $85.04. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. GE HealthCare Technologies Inc. has a 52-week low of $72.52 and a 52-week high of $94.55.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a dividend of $0.035 per share. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Insider Buying and Selling

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.